SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-038714
Filing Date
2019-08-09
Accepted
2019-08-09 08:31:21
Documents
64
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv526456_10q.htm 10-Q 749960
2 EXHIBIT 31.1 tv526456_ex31-1.htm EX-31.1 10808
3 EXHIBIT 31.2 tv526456_ex31-2.htm EX-31.2 10692
4 EXHIBIT 32.1 tv526456_ex32-1.htm EX-32.1 3827
5 EXHIBIT 32.2 tv526456_ex32-2.htm EX-32.2 3933
6 GRAPHIC image_002.jpg GRAPHIC 28002
7 GRAPHIC tv526456_img01.jpg GRAPHIC 11490
  Complete submission text file 0001144204-19-038714.txt   3889620

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrkr-20190630_def.xml EX-101.DEF 72963
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrkr-20190630_lab.xml EX-101.LAB 230482
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrkr-20190630_pre.xml EX-101.PRE 193334
11 XBRL INSTANCE DOCUMENT mrkr-20190630.xml EX-101.INS 934284
12 XBRL TAXONOMY EXTENSION SCHEMA mrkr-20190630.xsd EX-101.SCH 37916
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrkr-20190630_cal.xml EX-101.CAL 33458
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 191011411
SIC: 2834 Pharmaceutical Preparations